Influence of Insurance Status on Survival of Surgically Treated Esophageal Cancer Patients.
- Author:
Yoohwa HWANG
1
;
Se Jin OH
;
Jae Sung CHOI
;
Ji Won KIM
;
Jeong Sang LEE
;
Hyun Jong MOON
Author Information
- Publication Type:Original Article
- Keywords: Esophageal neoplasm; Surgery; Insurance coverage; Survival
- MeSH: Delivery of Health Care; Disease-Free Survival; Esophageal Neoplasms*; Fibrinogen; Humans; Incidence; Insurance Coverage*; Insurance*; Length of Stay; Medicare; Mortality; National Health Programs; Pneumonia; Postoperative Complications; Socioeconomic Factors; Survival Rate
- From:The Korean Journal of Gastroenterology 2018;72(1):15-20
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND/AIMS: Socioecomomic factor is an important determinant of access to healthcare and is one of the potential causes of disparities in esophageal cancer care outcomes. The aim of the study was to clarify the association between National health Insurance status (health insurance vs. medicare) as a socioeconomic factor and survival of patients with esophageal cancer who underwent surgical resection. METHODS: Among the 66 patients who underwent surgical resection for esophageal cancer between January 2006 and December 2017, 17 patients (25.8%) were in the medicare group. The data were analyzed to identify clinical manifestations and to compare surgical and oncologic outcomes between the groups. RESULTS: There was no significant difference in the distribution of sex (p=0.13), age (p=0.24), and pathologic stage (p=0.61) between the groups. The length of median hospital stay was significantly shorter in the healthy insurance group (18 days vs. 25 days, p=0.04). In the medicare group, postoperative mortality rates and incidence of postoperative complication were non-significantly higher (11.8% vs. 6.1%, p=0.45, 64.7% vs. 46.7%, p=0.21, respectively). However, pulmonary complication rates, including pneumonia, acute respiratory distress syndorme, and prolonged air leakage was significantly higher in the medicare group (47.1% vs. 18.4%, p=0.02). Five-year disease free survival rate was not different between the two groups (61.0% vs. 54.5%, p=0.68); the 5-year overall survival rate was significantly lower in the medicare group (27.7% vs. 53.7%, p=0.03). CONCLUSIONS: The medicare status of National health insurance could have a negative influence on the overall survival in patients with esophageal cancer who underwent surgery.
